Candel Therapeutics, Inc. has entered into an underwriting agreement to sell 10 million shares at $6.00 each and pre-funded warrants, aiming to raise approximately $74.7 million for product development and corporate purposes.
AI Assistant
CANDEL THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.